Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Apexigen Adds $65 Million to C Round in Funding Led by China Investors

publication date: Mar 25, 2020

Apexigen, a Bay Area clinical-stage biopharma, closed a $65 million second tranche of its C round that was led by two China investment firms, Decheng and Oceanpine. Last year, Apexigen raised $58 million in the first arm of the C round. Apexigen is developing immunotherapies for oncology, including APX005M, a mAb targeting CD40. Binding of APX005M to CD40 on antigen presenting cells (dendritic cells, monocytes and B-cells) is expected to activate both innate and adaptive immune systems. APX005M is currently being tested in several Phase II trials in multiple solid tumor cancers. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here